Navigation Links
Investment and Growth in US Medical Technology Industry Continues Despite Challenging Public Markets
Date:9/22/2008

ough June 2008, the US industry raised approximately US$1.7 billion, putting it on track to equal or surpass the average from the two previous years.

-- IPOs. While 13 initial public offerings (IPOs) were successfully completed in 2007, only three were completed in the first half of 2008. Total 2007 funding through IPOs rose to US$1.1 billion, a 54% increase over 2006. The average valuation at the time of the IPO swelled to US$405 million, a 94% increase over 2006.

-- IPO performance. Eight out of the 13 medtech companies that went public in 2007 saw gains from their initial IPO valuations during the year, which led to an average return of 24% for the year. However, these companies were significantly impacted by the challenging market conditions this year, with an average return of minus 4% through June 2008.

-- Booming deal space. The medtech M&A environment continues to be strong in 2007 and the first half of 2008. The total value of M&As was $49 billion in 2007, an 83% increase over 2006 after adjusting for the skewing impact of three mega mergers in 2006. Through the first half of 2008, the total value of M&A in the sector was approximately US$19 billion, a slightly lower pace than 2007, but still strong relative to years prior.

-- New generations of buyers. In addition to high deal volume, the base of buyers in medtech M&As has broadened. Many of the biggest medtech acquisitions in 2007 and the first half of 2008 were driven by two nontraditional participants: globally diversified conglomerates and private equity funds. While medtech-medtech mergers still represent the bulk of deals (through June 2008, these deals represented 81% of all M&A deals, or 54% of total deal value) mid-tier medtech buyers have become increasingly visible, supplementing the large cap medtech firms that have traditionally dominated.

-- Financial performance. Revenue for "pure-play" medtech companies increased by 6% in 2007 from the previous year, to US
'/>"/>

SOURCE Ernst & Young LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts
2. Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
3. Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment
4. Abbott to Present at UBS Best of Americas Investment Conference
5. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
6. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
8. The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future
9. Will New Technological Advances Offer Fresh Capabilities for Commercialization and Enhance BTL Investments?
10. Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities.
11. Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: ... 1360 Almshouse Road, Warrington, Pa. , Details: The ... to finding a cure for hepatitis B and improving the ... annual Crystal Ball on Friday, April 11 at Warrington Country ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up their ... of them wrote: "Take better care of my furry companion." Nowadays ... clothes and top-brand carrying cases to take the little canine or ... also feel compelled to buy some pricey toys at the pet ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management ... Product Strategy. In this role, Michelle will work with current ... in the development of iLab products. Her main goal will ... to the scientific community by offering the most advanced, user-friendly, ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... ,, PORTLAND, Ore. , June 15 ... the use of genomic data in clinical decision making—will be addressing ... in personalized treatments for cancer patients. , ... "If you were diagnosed with non ...
... and WALTHAM, Mass. , June 15, 2010 ... LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) today announced results ... superiority of BYDUREON™ (exenatide extended-release for injectable suspension), an investigational type 2 diabetes ... , , ...
... ... have entered into a research collaboration with the goal of bringing more relevant and ... ... -- Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with ...
Cached Biology Technology:Personalized Treatments for Cancer Are Revolutionizing Patient Care 2Personalized Treatments for Cancer Are Revolutionizing Patient Care 3DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 2DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 3DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 4DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 5DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 6DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 7DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 8DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 9Promega and Cellular Dynamics Partner to Validate Stem Cell-Based In Vitro Assays for Predicting Drug-Induced Cardiotoxicity 2Promega and Cellular Dynamics Partner to Validate Stem Cell-Based In Vitro Assays for Predicting Drug-Induced Cardiotoxicity 3
(Date:4/23/2014)... EMBO today announced Sophie Martin of the University ... EMBO Gold Medal. The award acknowledges her work to ... development of the cell. , Martin has been working ... in particular the way in which the spatial organization ... In the last 11 years, she has been using ...
(Date:4/23/2014)... Like many social mammals, ravens form different types of ... partners and they also form strict dominance relations. From ... is a key ability in daily social life ("knowing ... relationships group members have with each other sets the ... The results of this study have been published in ...
(Date:4/22/2014)... There are all sorts of signaling strategies in nature. ... tails; satin bowbirds build specialized stick structures, called bowers, ... European bitterling males show off bright nuptial coloration during ... to communicate with others. , ... profound fitness implications for individuals that are either signaling ...
Breaking Biology News(10 mins):EMBO Gold Medal 2014 awarded to Sophie Martin 2Ravens understand the relations among others 2Best practices in communication for the animal world 2Best practices in communication for the animal world 3
... shows that male rats prenatally exposed to low doses of ... prostate inflammation and to go through puberty later than non-exposed ... on atrazine, an herbicide predominantly used to control weeds and ... and its byproducts are known to be relatively persistent in ...
... desire to understand how breast cancer starts has seen ... today win one of three 2010 L,Oreal Australia For ... postdoctoral fellow in the institute,s Stem Cells and Cancer ... profile for her studies of how breast stem cells ...
... FL Nova Southeastern University (NSU) is using part of a ... the Gulf Oil Spill,s impact on the marine ecosystem, officials ... of several educational institutions in Florida selected to work on ... the Gulf,s ecosystem and marine life. The projects were selected ...
Cached Biology News:Atrazine causes prostate inflammation in male rats and delays puberty 2L'Oreal Fellowship winner seeks to understand breast cancer 2NSU scientists receive BP money to research oil spill's impact 2
... RNase ONE Ribonuclease is a 27kDa periplasmic ... degradation of RNA to cyclic nucleotide monophosphate ... degradation of these intermediates to 3-NMPs (1). ... few known RNases that can cleave a ...
The Holten Safe 2010 Class II Biological Safety Cabinets provide the most ergonomical working condition of comfort while incorporating the latest technology for safety, efficiency and performance....
... HM-4000 Multidizer is designed with a variety ... rotating - all in one unit. Shake, ... independently operating compartments allow for hybridization and ... motion , The upper chamber uses ...
... is designed for paramagnetic bead precipitation from ... PCR plates with no additional accessories. The ... a standard SBS 96-well microplate footprint. The ... guarantees easy and fast (as little as ...
Biology Products: